Duloxetine for the Treatment of Major Depression in Midlife Women: Effects on Brain Structure and Functioning, Mood, and Quality of Life.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 07 Feb 2012 Planned end date changed from 1 Apr 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 03 Jul 2009 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Jun 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.